Jeffrey H. Lipton

Jeffrey H. Lipton

55 Harbord St, M5S 2 W6
Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 271 publications

Jewish Tradition and Patient Communication.

Jewish Tradition and Patient Communication.

Journal: The Israel Medical Association journal : IMAJ

Published: September 06, 2026

Milestones in the Evolution of Allogeneic Stem Cell Transplantation. Part I.

Milestones in the Evolution of Allogeneic Stem Cell Transplantation. Part I.

Journal: Transplantation and cellular therapy

Published: September 04, 2026

Breast cancer risk among survivors of hematopoietic stem cell transplant with or without total body irradiation: A population-based analysis.

Breast cancer risk among survivors of hematopoietic stem cell transplant with or without total body irradiation: A population-based analysis.

Journal: Transplantation and cellular therapy

Published: July 14, 2026

Reframing chronic myeloid leukemia outcomes beyond survival: a perspective of quality of life and patient-centered data.

Reframing chronic myeloid leukemia outcomes beyond survival: a perspective of quality of life and patient-centered data.

Journal: Blood reviews

Published: May 19, 2026

CMV reactivation post allogeneic stem cell transplantation decreases relapse risk and survival, and increases NRM - a single center analysis.

CMV reactivation post allogeneic stem cell transplantation decreases relapse risk and survival, and increases NRM - a single center analysis.

Journal: Leukemia & lymphoma

Published: May 14, 2026

Bistable Networks Enable Complex Shape Changes.

Bistable Networks Enable Complex Shape Changes.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 24, 2026

Five-year follow-up of OPTIC: long-term efficacy, safety, and mutation analyses of ponatinib in chronic-phase chronic myeloid leukemia from a randomized phase 2 trial.

Five-year follow-up of OPTIC: long-term efficacy, safety, and mutation analyses of ponatinib in chronic-phase chronic myeloid leukemia from a randomized phase 2 trial.

Journal: Leukemia

Published: March 30, 2026

Prior Malignancy History and Risk of Second Malignancies After Allogeneic Hematopoietic Cell Transplantation.

Prior Malignancy History and Risk of Second Malignancies After Allogeneic Hematopoietic Cell Transplantation.

Journal: Transplantation and cellular therapy

Published: March 21, 2026

Allogeneic HSCT in Aplastic Anemia: Current Evidence, Controversies, and Practical Decision-Making.

Allogeneic HSCT in Aplastic Anemia: Current Evidence, Controversies, and Practical Decision-Making.

Journal: American journal of hematology

Published: March 05, 2026

The Role of Allogeneic Hematopoietic Cell Transplantation in the Management of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors.

The Role of Allogeneic Hematopoietic Cell Transplantation in the Management of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors.

Journal: American journal of hematology

Published: February 23, 2026

The Effect of Smoking and Pre-Allogeneic Hematopoietic Cell Transplant Pulmonary Comorbidity on the Incidence of Lung Graft-Versus-Host Disease and Post-Transplant Outcomes.

The Effect of Smoking and Pre-Allogeneic Hematopoietic Cell Transplant Pulmonary Comorbidity on the Incidence of Lung Graft-Versus-Host Disease and Post-Transplant Outcomes.

Journal: Cancers

Published: November 26, 2025

Outcomes of Dyskeratosis Congenita: Results From the Canadian Inherited Marrow Failure Registry.

Outcomes of Dyskeratosis Congenita: Results From the Canadian Inherited Marrow Failure Registry.

Journal: Journal of pediatric hematology/oncology

Published: October 28, 2025

Showing 1-12 of 271

Last Updated: 09/26/2026